Stock Chart
COLL
Type: SELL wallstreet
Strike: $50
Premium: $3.02
Expiry: Mar 20, 2026
Target: $47
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About COLL - Collegium Pharmaceutical, Inc. Common Stock
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and …
Key Statistics
More COLL Analysis
This COLL stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track COLL's price movements with trendlines, gamma walls, and key support/resistance levels.